IE822486L - 3-benzazepines as alpha-2-antagonists - Google Patents

3-benzazepines as alpha-2-antagonists

Info

Publication number
IE822486L
IE822486L IE248682A IE248682A IE822486L IE 822486 L IE822486 L IE 822486L IE 248682 A IE248682 A IE 248682A IE 248682 A IE248682 A IE 248682A IE 822486 L IE822486 L IE 822486L
Authority
IE
Ireland
Prior art keywords
benzazepines
compositions
producing
antagonists
alpha
Prior art date
Application number
IE248682A
Other versions
IE53962B1 (en
Original Assignee
Smithkline Beckman Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/398,015 external-priority patent/US4465677A/en
Application filed by Smithkline Beckman Corp filed Critical Smithkline Beckman Corp
Publication of IE822486L publication Critical patent/IE822486L/en
Publication of IE53962B1 publication Critical patent/IE53962B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)

Abstract

Pharmaceutical Compositions and Method of Producing Alpha2 Antagonism Pharmaceutical compositions and method of producing alpha2 antagonism by administering N-substituted 2,3,4,5-tetrahydro-1H-3-benzazepines. These compositions are particularly useful for lowering intraocular pressure and for the treatment of cardiovascular conditions such as, for example, congestive heart failure, angina pectoris, and thrombosis. The compositions and compounds of this invention also produce a reduction in blood pressure and are therefore useful as antihypertensive agents. [CA1214165A]
IE248682A 1981-11-27 1982-10-14 3-benzazepines as alpha-2 antagonists IE53962B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32524981A 1981-11-27 1981-11-27
US06/398,015 US4465677A (en) 1982-07-14 1982-07-14 Pharmaceutical compositions and method of producing alpha2 antagonism

Publications (2)

Publication Number Publication Date
IE822486L true IE822486L (en) 1983-05-27
IE53962B1 IE53962B1 (en) 1989-04-26

Family

ID=26984843

Family Applications (1)

Application Number Title Priority Date Filing Date
IE248682A IE53962B1 (en) 1981-11-27 1982-10-14 3-benzazepines as alpha-2 antagonists

Country Status (18)

Country Link
AU (1) AU555672B2 (en)
CA (1) CA1214165A (en)
DD (1) DD205896A5 (en)
DK (1) DK493182A (en)
EG (1) EG16524A (en)
ES (1) ES8405769A1 (en)
FI (1) FI823715L (en)
GR (1) GR77702B (en)
IE (1) IE53962B1 (en)
IL (1) IL67092A (en)
NO (1) NO158537C (en)
NZ (1) NZ202245A (en)
PH (1) PH18471A (en)
PL (1) PL136452B1 (en)
PT (1) PT75838B (en)
RO (1) RO85262B (en)
YU (1) YU265782A (en)
ZW (1) ZW23382A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4541954A (en) * 1984-09-05 1985-09-17 Smithkline Beckman Corporation Method for preparing 6-chloro-N-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine

Also Published As

Publication number Publication date
ES517697A0 (en) 1984-06-16
NO158537C (en) 1988-09-28
NO158537B (en) 1988-06-20
PL239244A1 (en) 1984-01-02
FI823715A0 (en) 1982-11-01
AU555672B2 (en) 1986-10-02
IE53962B1 (en) 1989-04-26
DK493182A (en) 1983-05-28
IL67092A0 (en) 1983-02-23
RO85262B (en) 1984-10-30
NZ202245A (en) 1985-09-13
ES8405769A1 (en) 1984-06-16
GR77702B (en) 1984-09-25
CA1214165A (en) 1986-11-18
PL136452B1 (en) 1986-02-28
DD205896A5 (en) 1984-01-11
NO823990L (en) 1983-05-30
PT75838B (en) 1985-11-12
FI823715L (en) 1983-05-28
IL67092A (en) 1987-09-16
PH18471A (en) 1985-07-18
YU265782A (en) 1984-12-31
ZW23382A1 (en) 1983-01-26
EG16524A (en) 1989-06-30
AU9017282A (en) 1983-06-02
RO85262A (en) 1984-09-29
PT75838A (en) 1982-12-01

Similar Documents

Publication Publication Date Title
NZ247642A (en) Thioalkylacyl substituted heterocyclic compounds; pharmaceutical compositions and preparatory methods
PL285591A1 (en) Method for manufacturing new imidazolilalkenecrbxylic acids
HUT49571A (en) Process for producing substituted pyrrol-, pyrazol- and triazol derivatives and pharmaceutical compositions containing them
HU913497D0 (en) Process for the production of 3-(2h)-piridazinone-derivatives, and medical preparations containing such active agents
AU5139085A (en) Bicyclic heterocyclic piperazine derivatives
IE902139L (en) Imidazolyl alkenoic acids
IE810236L (en) Sulfamoyl derivatives.
IE901594L (en) Azaindenes
HU894581D0 (en) Alkoxy-4(1h)-pyridone derivatives, process for producing these compounds and pharmaceutical preparatives containing them as active substance
TW226375B (en)
MY131595A (en) Heterocyclically substituted phenyl-cyclohexane- carboxylic acid derivatives
PT81308B (en) Process for preparing a combination of dihydropyridines with ace(angiotensin converting enzymes) inhibitors useful as medicament
HUT56077A (en) Process for producing n-(imidazolyl-alkyl)-alanyl derivatives with substituents and pharmaceutical compositions containing them as active components
AU7424587A (en) 2-Phenylbenzoxepin derivative
ES8703150A1 (en) New B-Carboline-3-oxadiazolyl derivatives, method of preparing the same and their use.
PL305457A1 (en) Galantamine derivatives, method of obtaining them and their application as drugs
ES8704482A1 (en) Method of treating liver diseases using pure silibinin
HUT37792A (en) Process for production of derivatives of beta-carbolin-3-carbonic acid and medical preparatives containing such compounds
IE822486L (en) 3-benzazepines as alpha-2-antagonists
CA2275253A1 (en) Method for producing n-substituted 3-hydroxypyrazoles
RU93057746A (en) A NEW METHOD FOR PRODUCING SULFUR-PRODUCED IMIDAZOLE DERIVATIVES AND NEW RECEIVED INTERMEDIATE PRODUCTS
EP0369743A3 (en) Heterocyclic amides
EP0351795A3 (en) Novel deoxyadenosine compounds and methods of making and using the same
PH24636A (en) Method of treating heart failure
MX9600165A (en) 3-alkoxycarbonylthiadiazinonas, process for the preparation thereof and pharmaceutical compositions containing them.